-Hans Wilhelm Doerr Researcher Activity Profile

Research Author Detailed Information 

Hans Wilhelm Doerr Publication Rate By Year

Hans Wilhelm Doerr has published 1 paper(s) in 1985, 1 paper(s) in 1987, 1 paper(s) in 2006, 24 paper(s) in 2007, 6 paper(s) in 2008, for a total of 33 research publications in total.

Hans Wilhelm Hw Doerr Author Information

LAST NAME: doerr

FIRST NAME: Hans Wilhelm

INITIALS: hw

AFFILIATION:

Papers

Hans Wilhelm Doerr's Publication Record

1. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. Year Published: 2006
Crucell Holland B.V., Leiden, Netherlands. j.termeulen@crucell.com
2. Molecular assays for monitoring HIV infection and antiretroviral therapy. Year Published: 2007
Institute for Medical Virology, JW Goethe University Hospital, Frankfurt, Germany. miriam.wittek@gmx.de
3. Seroprevalence of vaccine preventable and blood transmissible viral infections (measles, mumps, rubella, polio, HBV, HCV and HIV) in medical students. Year Published: 2007
Occupational Health Service, University Hospital of Frankfurt, 60590, Frankfurt/Main, Germany.
4. The threat of avian influenza a (H5N1): part II: Clues to pathogenicity and pathology. Year Published: 2007
Institute for Medical Virology, Hospital of the Johann Wolfgang Goethe University, Paul-Ehrlich-Str. 40, 60596, Frankfurt/M, Germany, cinatl@em.uni-frankfurt.de.
5. The threat of avian influenza A (H5N1). Part III: antiviral therapy. Year Published: 2007
Institute for Medical Virology, Hospital of the Johann Wolfgang Goethe University, Paul-Ehrlich-Str. 40, 60596, Frankfurt/M, Germany, cinatl@em.uni-frankfurt.de.
6. The threat of avian influenza A (H5N1). Part I: epidemiologic concerns and virulence determinants. Year Published: 2007
Institute for Medical Virology, Hospital of the Johann Wolfgang Goethe University, Paul-Ehrlich-Str. 40, 60596, Frankfurt/M, Germany, cinatl@em.uni-frankfurt.de.
7. The threat of avian influenza A (H5N1). Part IV: development of vaccines. Year Published: 2007
Institute for Medical Virology, Hospital of the Johann Wolfgang Goethe University, Paul-Ehrlich-Str. 40, 60596, Frankfurt/M, Germany, cinatl@em.uni-frankfurt.de.
8. Association of saquinavir plasma concentrations with side effects but not with antiretroviral outcome in patients infected with protease inhibitor-susceptible human immunodeficiency virus type 1. Year Published: 2007
Pharmazentrum Frankfurt/ZAFES, Institute of Clinical Pharmacology, Johann Wolfgang Goethe University, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany. j.loetsch@em.uni-frankfurt.de
9. Valproic acid as anti-cancer drug. Year Published: 2007
10. Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells. Year Published: 2007
11. Novel approach for genotyping varicella-zoster virus strains from Germany. Year Published: 2007
Institute of Medical Virology, Hospital of the Johann Wolfgang Goethe University, Paul Ehrlich Strasse 40, D-60596, Frankfurt am Main, Germany. jonassi@gmx.de
12. Valproic acid as anti-cancer drug. Year Published: 2007
13. The threat of avian influenza a (H5N1): part II: Clues to pathogenicity and pathology. Year Published: 2007
Institute for Medical Virology, Hospital of the Johann Wolfgang Goethe University, Paul-Ehrlich-Str. 40, 60596, Frankfurt/M, Germany. cinatl@em.uni-frankfurt.de
14. The threat of avian influenza A (H5N1). Part III: Antiviral therapy. Year Published: 2007
Institute for Medical Virology, Hospital of the Johann Wolfgang Goethe University, Paul-Ehrlich-Str. 40, 60596, Frankfurt/M, Germany. cinatl@em.uni-frankfurt.de
15. The threat of avian influenza A (H5N1). Part I: Epidemiologic concerns and virulence determinants. Year Published: 2007
Institute for Medical Virology, Hospital of the Johann Wolfgang Goethe University, Paul-Ehrlich-Str. 40, 60596, Frankfurt/M, Germany. cinatl@em.uni-frankfurt.de
16. The threat of avian influenza A (H5N1). Part IV: Development of vaccines. Year Published: 2007
Institute for Medical Virology, Hospital of the Johann Wolfgang Goethe University, Paul-Ehrlich-Str. 40, 60596, Frankfurt/M, Germany. cinatl@em.uni-frankfurt.de
17. Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells. Year Published: 2007
18. Novel approach for genotyping varicella-zoster virus strains from Germany. Year Published: 2007
Institute of Medical Virology, Hospital of the Johann Wolfgang Goethe University, Paul Ehrlich Strasse 40, D-60596, Frankfurt am Main, Germany. jonassi@gmx.de
19. Phytochemical analysis and in vitro evaluation of the biological activity against herpes simplex virus type 1 (HSV-1) of Cedrus libani A. Rich. Year Published: 2007
Department of Pharmaceutical Sciences, University of Calabria, I-87036 Rende (CS), Italy.
20. The threat of avian influenza a (H5N1): part II: Clues to pathogenicity and pathology. Year Published: 2007
Institute for Medical Virology, Hospital of the Johann Wolfgang Goethe University, Paul-Ehrlich-Str. 40, 60596, Frankfurt/M, Germany. cinatl@em.uni-frankfurt.de
21. The threat of avian influenza A (H5N1). Part III: Antiviral therapy. Year Published: 2007
Institute for Medical Virology, Hospital of the Johann Wolfgang Goethe University, Paul-Ehrlich-Str. 40, 60596, Frankfurt/M, Germany. cinatl@em.uni-frankfurt.de
22. The threat of avian influenza A (H5N1). Part I: Epidemiologic concerns and virulence determinants. Year Published: 2007
Institute for Medical Virology, Hospital of the Johann Wolfgang Goethe University, Paul-Ehrlich-Str. 40, 60596, Frankfurt/M, Germany. cinatl@em.uni-frankfurt.de
23. The threat of avian influenza A (H5N1). Part IV: Development of vaccines. Year Published: 2007
Institute for Medical Virology, Hospital of the Johann Wolfgang Goethe University, Paul-Ehrlich-Str. 40, 60596, Frankfurt/M, Germany. cinatl@em.uni-frankfurt.de
24. Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells. Year Published: 2007
25. Association of saquinavir plasma concentrations with side effects but not with antiretroviral outcome in patients infected with protease inhibitor-susceptible human immunodeficiency virus type 1. Year Published: 2007
Pharmazentrum Frankfurt/ZAFES, Institute of Clinical Pharmacology, Johann Wolfgang Goethe University, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany. j.loetsch@em.uni-frankfurt.de
26. Novel varicella-zoster virus glycoprotein e gene mutations associated with genotypes a and d. Year Published: 2008
Bernhard-Nocht-Institute for Tropical Medicine, Clinical Virology Laboratory, Bernhard-Nocht-Strasse 74, 20359 Hamburg, Germany. jonassi@gmx.de.
27. Valproic acid interferes with antiviral treatment in human cytomegalovirus-infected endothelial cells. Year Published: 2008
28. Predictive factors for response to a boosted dual HIV-protease inhibitor therapy with saquinavir and lopinavir in extensively pre-treated patients. Year Published: 2008
Pharmazentrum Frankfurt, Department of Virology, JohannWolfgang Goethe University Hospital, Frankfurt, Germany. Hentig@em.uni-frankfurt.de
29. Incidences of antibodies to hepatitis B, herpes simplex and cytomegalovirus in prostitutes. Year Published: 1985
30. Humoral immune response after hepatitis-B-vaccination: kinetics of anti-HBs antibodies and demonstration of HLA antigens. Year Published: 1987
31. Novel varicella-zoster virus glycoprotein E gene mutations associated with genotypes A and D. Year Published: 2008
Institute of Medical Virology, Hospital of the Johann Wolfgang Goethe University, D-60596 Frankfurt am Main, Germany. jonassi@gmx.de
32. Phytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon species. Year Published: 2008
Department of Pharmaceutical Sciences, Faculty of Pharmacy and Health Sciences and Nutrition, University of Calabria, I-87036 Rende (CS). mr.loizzo@unical.it
33. Valproic acid interferes with antiviral treatment in human cytomegalovirus-infected endothelial cells. Year Published: 2008